These data may explain why our colorimetric assays failed to detect changes in pyruvate levels in glioma cells: when the expression of NKILA was upregulated, the rate of pyruvate production increased, and the rate of conversion of pyruvate into lactic acid also increased. Here, NKILA is linked to central nervous system cancer.